Alexis Pinto - Net Worth and Insider Trading

Alexis Pinto Net Worth

The estimated net worth of Alexis Pinto is at least $87,959 dollars as of 2024-11-08. Alexis Pinto is the Chief Legal Officer of Zentalis Pharmaceuticals Inc and owns about 22,240 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $87,959. Details can be seen in Alexis Pinto's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alexis Pinto has not made any transactions after 2022-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alexis Pinto

To

Alexis Pinto Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alexis Pinto owns 1 companies in total, including Zentalis Pharmaceuticals Inc (ZNTL) .

Click here to see the complete history of Alexis Pinto’s form 4 insider trades.

Insider Ownership Summary of Alexis Pinto

Ticker Comapny Transaction Date Type of Owner
ZNTL Zentalis Pharmaceuticals Inc 2022-02-14 Chief Legal Officer

Alexis Pinto Latest Holdings Summary

Alexis Pinto currently owns a total of 1 stock. Alexis Pinto owns 22,240 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of February 14, 2022, with a value of $87,959.

Latest Holdings of Alexis Pinto

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZNTL Zentalis Pharmaceuticals Inc 2022-02-14 22,240 3.96 87,959

Holding Weightings of Alexis Pinto


Alexis Pinto Form 4 Trading Tracker

According to the SEC Form 4 filings, Alexis Pinto has made a total of 2 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the sale of 691 shares on February 14, 2022, which brought Alexis Pinto around $34,709.

Insider Trading History of Alexis Pinto

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alexis Pinto Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alexis Pinto Ownership Network

Ownership Network List of Alexis Pinto

No Data

Ownership Network Relation of Alexis Pinto

Insider Network Chart

Alexis Pinto Owned Company Details

What does Zentalis Pharmaceuticals Inc do?

Who are the key executives at Zentalis Pharmaceuticals Inc?

Alexis Pinto is the Chief Legal Officer of Zentalis Pharmaceuticals Inc. Other key executives at Zentalis Pharmaceuticals Inc include Chief Financial Officer Melissa B, Epperly , General Counsel Andrea Paul , and Chief Medical Officer Carrie Brownstein .

Zentalis Pharmaceuticals Inc (ZNTL) Insider Trades Summary

Over the past 18 months, Alexis Pinto made no insider transaction in Zentalis Pharmaceuticals Inc (ZNTL). Other recent insider transactions involving Zentalis Pharmaceuticals Inc (ZNTL) include a net sale of 50,090 shares made by Cam Gallagher , a net sale of 16,724 shares made by Melissa B, Epperly , and a net sale of 86,068 shares made by Kevin D. Bunker .

In summary, during the past 3 months, insiders sold 1,603 shares of Zentalis Pharmaceuticals Inc (ZNTL) in total and bought 0 shares, with a net sale of 1,603 shares. During the past 18 months, 178,364 shares of Zentalis Pharmaceuticals Inc (ZNTL) were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 156,364 shares.

Zentalis Pharmaceuticals Inc (ZNTL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zentalis Pharmaceuticals Inc Insider Transactions

No Available Data

Alexis Pinto Mailing Address

Above is the net worth, insider trading, and ownership report for Alexis Pinto. You might contact Alexis Pinto via mailing address: C/o Zentalis Pharmaceuticals, Llc, 530 Seventh Avenue, Suite 2201, New York Ny 10018.